Galapagos Nv
Clinical trials sponsored by Galapagos Nv, explained in plain language.
-
New pill tested to tame debilitating muscle and skin disease
Disease control OngoingThis study is testing a daily oral medication called GLPG3667 to see if it can safely reduce disease activity and improve symptoms in adults with dermatomyositis, a condition that causes muscle weakness and skin rashes. About 40 participants will take either the drug or a placebo…
Phase: PHASE2 • Sponsor: Galapagos NV • Aim: Disease control
Last updated Apr 02, 2026 14:56 UTC
-
New pill tested to tame overactive immune system in lupus
Disease control OngoingThis study is testing whether a daily oral pill called GLPG3667 can safely reduce disease activity in adults with active systemic lupus erythematosus (SLE). About 180 participants will take either the study drug or a placebo for 48 weeks while continuing their standard lupus medi…
Phase: PHASE2 • Sponsor: Galapagos NV • Aim: Disease control
Last updated Mar 10, 2026 12:53 UTC
-
Faster-Made Cancer-Fighting cells tested in major lymphoma trial
Disease control OngoingThis study is testing an experimental CAR-T cell therapy called GLPG5101 for people whose B-cell non-Hodgkin lymphoma has come back or hasn't responded to other treatments. The goal is to find the safest and most effective dose and see if this new therapy, which is made at the tr…
Phase: PHASE1, PHASE2 • Sponsor: Galapagos NV • Aim: Disease control
Last updated Mar 06, 2026 15:39 UTC